South Tulsa Pathology Laboratory v. Commissioner
United States Tax Court
118 T.C. 84 (2002)
- Written by Heather Ryfa, JD
Facts
The shareholders of South Tulsa Pathology Laboratory, Inc. (South Tulsa) (plaintiff) negotiated a sale of a portion of South Tulsa’s business to National Health Laboratories, Inc. (NHL). In order to accomplish this sale, the subject assets of South Tulsa were transferred to a newly formed subsidiary corporation, Clinpath, Inc., in exchange for all of Clinpath’s stock. Clinpath stock was immediately distributed to the shareholders of South Tulsa, who then sold this stock to NHL. South Tulsa contended that this transaction was entitled to nonrecognition as a D reorganization under § 368(a)(1)(D) of the Internal Revenue Code. The commissioner of the Internal Revenue Service (defendant) assessed a deficiency, determining that the distribution of Clinpath’s stock to South Tulsa’s shareholders did not qualify for nonrecognition under § 355 because the transaction was a device to distribute earnings and profits. South Tulsa appealed the assessment to the United States Tax Court.
Rule of Law
Issue
Holding and Reasoning (Marvel, J.)
What to do next…
Here's why 810,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
